Study confirms beneficial effect of Tri-Low full spectrum Amla extract upon dyslipidemia
March 22, 2019
Lipid balance was achieved with no concomitant reduction of plasma CoQ10 levels, a phenomenon typically associated with a number of lipid-lowering drugs. Other related parameters, such as fasting blood glucose, homocysteine levels, and apo-B/apo lipoprotein levels, also tended to lower. This potentially widens Tri-low’s scope for targeting diabetic dyslipidemia.
Researchers have discovered that those who have a soy protein-rich diet reduce the amount of fatty deposits that accumulate around the liver, which can lead to liver disease.
Lipid and lipid components provide sensory, nutritional and functional aspects to foods and beverages. Emerging information on changing technologies, uses and health benefits of this macronutrient is provided.